Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study.
Adolescent
Age of Onset
Breast Feeding
Case-Control Studies
Child
Child, Preschool
Dietary Supplements
Female
Germany
/ epidemiology
Humans
Infant
Infant, Newborn
Male
Mucocutaneous Lymph Node Syndrome
/ epidemiology
Retrospective Studies
Risk Factors
Vitamin D
/ therapeutic use
Vitamins
/ therapeutic use
Breast feeding
Coronary artery aneurysm
Kawasaki disease
Risk factors
Vitamin D supplementation
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
26 02 2019
26 02 2019
Historique:
received:
31
08
2018
accepted:
18
02
2019
entrez:
28
2
2019
pubmed:
28
2
2019
medline:
5
3
2020
Statut:
epublish
Résumé
In Kawasaki disease (KD), a vasculitis of unknown etiology, the most serious complication is the development of coronary artery aneurysm (CAA). To date, the exact pathomechanism of KD is unknown. Both environmental and genetic factors seem to be associated with the development of the disease. Data on KD patients recruited from the population-based German Pediatric Surveillance Study during 2012-2014 were used to evaluate the impact of various factors from the perinatal and infancy period on the development of KD. The study design was a matched case-control study with respect to age, sex and place of residence (n = 308 KD cases, n = 326 controls). All KD patients were individually re-evaluated; all fulfilled the international diagnostic KD criteria. A standardized questionnaire was used to review breastfeeding practices, vitamin D supplementation and birth characteristics. Logistic regression analyses were performed to obtain odds ratios (OR) for various risk factors among the case-control pairs. Simple measures of association were used to assess the impact of these factors on the clinical course. There was no difference in lengths of gestation, birth weight or parturition between KD patients and controls, but independently from each other vitamin D supplementation and breastfeeding were negatively associated with KD, even when adjusted for age, place of residence and sex. The duration of vitamin D was significantly shorter among children with KD than among children without KD (p = 0.039, OR = 0.964, 95% CI: 0.931-0.998), as was the duration of breastfeeding (p = 0.013, OR = 0.471, 95% CI: 0.260-0.853). Comparing KD patients with and without breastfeeding and/or vitamin D supplementation, there were no differences regarding developing CAA, being refractory to intravenous immunoglobulin treatment, age at onset of the disease and levels of inflammatory laboratory values. Our findings indicate breastfeeding and vitamin D supplementation to have protective effects in association with KD in our study population; however, these seem not to influence the natural course of the disease. Although the overall effects were relatively small, they nevertheless underline the overall benefit of both interventions. Clinical Trial Registration: German clinical trial registration, http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00010071 . Date of registration was 26. February 2016. The trial was registered retrospectively.
Sections du résumé
BACKGROUND
In Kawasaki disease (KD), a vasculitis of unknown etiology, the most serious complication is the development of coronary artery aneurysm (CAA). To date, the exact pathomechanism of KD is unknown. Both environmental and genetic factors seem to be associated with the development of the disease.
METHODS
Data on KD patients recruited from the population-based German Pediatric Surveillance Study during 2012-2014 were used to evaluate the impact of various factors from the perinatal and infancy period on the development of KD. The study design was a matched case-control study with respect to age, sex and place of residence (n = 308 KD cases, n = 326 controls). All KD patients were individually re-evaluated; all fulfilled the international diagnostic KD criteria. A standardized questionnaire was used to review breastfeeding practices, vitamin D supplementation and birth characteristics. Logistic regression analyses were performed to obtain odds ratios (OR) for various risk factors among the case-control pairs. Simple measures of association were used to assess the impact of these factors on the clinical course.
RESULTS
There was no difference in lengths of gestation, birth weight or parturition between KD patients and controls, but independently from each other vitamin D supplementation and breastfeeding were negatively associated with KD, even when adjusted for age, place of residence and sex. The duration of vitamin D was significantly shorter among children with KD than among children without KD (p = 0.039, OR = 0.964, 95% CI: 0.931-0.998), as was the duration of breastfeeding (p = 0.013, OR = 0.471, 95% CI: 0.260-0.853). Comparing KD patients with and without breastfeeding and/or vitamin D supplementation, there were no differences regarding developing CAA, being refractory to intravenous immunoglobulin treatment, age at onset of the disease and levels of inflammatory laboratory values.
CONCLUSION
Our findings indicate breastfeeding and vitamin D supplementation to have protective effects in association with KD in our study population; however, these seem not to influence the natural course of the disease. Although the overall effects were relatively small, they nevertheless underline the overall benefit of both interventions.
TRIAL REGISTRATION
Clinical Trial Registration: German clinical trial registration, http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00010071 . Date of registration was 26. February 2016. The trial was registered retrospectively.
Identifiants
pubmed: 30808315
doi: 10.1186/s12887-019-1438-2
pii: 10.1186/s12887-019-1438-2
pmc: PMC6390341
doi:
Substances chimiques
Vitamins
0
Vitamin D
1406-16-2
Banques de données
DRKS
['DRKS00010071']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
66Références
Atherosclerosis. 2009 Jul;205(1):255-60
pubmed: 19091317
Pediatrics. 2010 Jul;126(1):e18-25
pubmed: 20566605
J Steroid Biochem Mol Biol. 2009 Jan;113(1-2):134-8
pubmed: 19138739
J Clin Endocrinol Metab. 2011 Jan;96(1):53-8
pubmed: 21118827
Circulation. 2004 Oct 26;110(17):2747-71
pubmed: 15505111
J Epidemiol. 2015;25(3):239-45
pubmed: 25716368
Clin Rheumatol. 2016 Jul;35(7):1865-72
pubmed: 25994612
Semin Perinatol. 1994 Dec;18(6):495-501
pubmed: 7701351
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Mar;18(3):211-4
pubmed: 26975816
J Pediatr. 2016 Jun;173 Suppl:S43-52
pubmed: 27234411
Pediatr Infect Dis J. 2016 Feb;35(2):129-34
pubmed: 26465100
J Am Coll Cardiol. 2011 Jul 5;58(2):186-92
pubmed: 21718915
BMJ. 2016 Feb 25;352:i969
pubmed: 26916049
Dig Dis Sci. 1979 Nov;24(11):876-82
pubmed: 391518
Pediatrics. 2016 Jun;137(6):
pubmed: 27244853
J Clin Endocrinol Metab. 2015 Apr;100(4):1469-76
pubmed: 25668290
Pediatr Rev. 2018 Feb;39(2):78-90
pubmed: 29437127
Korean J Pediatr. 2017 Jul;60(7):216-220
pubmed: 28861112
Pediatr Int. 2009 Dec;51(6):812-6
pubmed: 19419530
Sci Total Environ. 2019 Mar 10;655:141-146
pubmed: 30469059
N Engl J Med. 1999 Apr 22;340(16):1234-8
pubmed: 10210706
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD003517
pubmed: 22895934
N Engl J Med. 1992 Apr 30;326(18):1213-5
pubmed: 1557095
J Autoimmun. 2017 Dec;85:78-97
pubmed: 28733125
Lancet. 2004 Aug 7-13;364(9433):533-44
pubmed: 15302199
J Clin Lab Anal. 2016 Sep;30(5):529-33
pubmed: 26661754
Clin Exp Immunol. 2006 Jan;143(1):58-64
pubmed: 16367934
Pediatrics. 2015 Jan;135(1):e92-8
pubmed: 25452656